Relaxant Effects of 17-β-Estradiol in Cerebral Arteries through Ca2+ Entry Inhibition
Authors:
Open Access
- 1 April 2001
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 21 (4) , 422-429
Abstract
Estrogens account for gender differences in the incidence and outcome of stroke, but it remains unclear to what extent neuroprotective effects of estrogens are because of parenchymal or vascular actions. Because reproductive steroids have vasoactive properties, the authors assessed the effects and mechanisms of action of 17-β-estradiol in rabbit isolated basilar artery. Cumulative doses of 17-β-estradiol (0.3 μmol/L to 0.1 mmol/L) induced concentration-dependent relaxation that was larger in basilar than carotid artery, in male than female basilar artery, and in KCl-precontracted than UTP-precontracted male basilar artery. Endothelium removal did not modify relaxation induced by 17-β-estradiol in basilar artery, whereas relaxation induced by acetylcholine (1 nmol/L to 0.1 mmol/L) was almost abolished. Neither the estrogen receptor antagonist ICI 182,780 (1 μmol/L), nor the protein synthesis inhibitor cycloheximide (1 μmol/L) affected 17-β-estradiol–induced relaxations. Relaxations induced by the K+ channel openers NS1619 and pinacidil in the same concentration range were greater and lower, respectively, when compared with relaxation to 17-β-estradiol, which was not significantly modified by incubation with the K+ channel blockers charybdotoxin (1 nmol/L and 0.1 μmol/L) or glibenclamide (10 nmol/L and 1 μmol/L). Preincubation with 17-β-estradiol (3 to 100 μmol/L) produced concentration-dependent inhibition of CaCl2-induced contraction, with less potency than the Ca2+ entry blocker nicardipine (0.01 to 10 nmol/L). The authors conclude that 17-β-estradiol induces endothelium-independent relaxation of cerebral arteries with tissue and gender selectivity. The relaxant effect is because of inhibition of extracellular Ca2+ influx to vascular smooth muscle, but activation of estrogen receptors, protein synthesis, or K+ efflux are not involved. Relatively high pharmacologic concentrations of 17-β-estradiol causing relaxation preclude acute vascular effects of physiologic circulating levels on the cerebral circulation.Keywords
This publication has 38 references indexed in Scilit:
- Estrogen Receptors α and βCirculation, 2000
- 17β-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female AnimalsStroke, 1999
- Estrogen-Mediated Neuroprotection After Experimental Stroke in Male RatsStroke, 1998
- Mechanism of Vascular Smooth Muscle Relaxation by Estrogen in Depolarized Rat and Mouse AortaCirculation Research, 1997
- Non‐genomic mechanism of 17 beta‐oestradiol‐induced inhibition of contraction in mammalian vascular smooth muscle.The Journal of Physiology, 1997
- Oestradiol‐induced relaxation of rabbit basilar artery by inhibition of voltage‐dependent Ca channels through GTP‐binding proteinBritish Journal of Pharmacology, 1996
- Estrogen Relaxes Coronary Arteries by Opening BKCaChannels Through a cGMP-Dependent MechanismCirculation Research, 1995
- Postischemic Cerebral Blood Flow Recovery in the Female: Effect of 17β-EstradiolJournal of Cerebral Blood Flow & Metabolism, 1995
- Increased Ca2+Influx in the Resting State Maintains the Myogenic Tone and Activates Charybdotoxin-Sensitive K+Channels in Dog Basilar ArteryJournal of Cerebral Blood Flow & Metabolism, 1993
- Endothelium‐independent relaxation of rabbit coronary artery by 17β‐oestradiol in vitroBritish Journal of Pharmacology, 1991